Cargando…
Therapeutic CFTR Correction Normalizes Systemic and Lung-Specific S1P Level Alterations Associated with Heart Failure
Heart failure (HF) is among the main causes of death worldwide. Alterations of sphingosine-1-phosphate (S1P) signaling have been linked to HF as well as to target organ damage that is often associated with HF. S1P’s availability is controlled by the cystic fibrosis transmembrane regulator (CFTR), wh...
Autores principales: | Uhl, Franziska E., Vanherle, Lotte, Matthes, Frank, Meissner, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777932/ https://www.ncbi.nlm.nih.gov/pubmed/35055052 http://dx.doi.org/10.3390/ijms23020866 |
Ejemplares similares
-
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
por: Uhl, Franziska E., et al.
Publicado: (2022) -
CFTR Therapeutics Normalize Cerebral Perfusion Deficits in Mouse Models of Heart Failure and Subarachnoid Hemorrhage
por: Lidington, Darcy, et al.
Publicado: (2019) -
Improving Cerebrovascular Function to Increase Neuronal Recovery in Neurodegeneration Associated to Cardiovascular Disease
por: Vanherle, Lotte, et al.
Publicado: (2020) -
Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia
por: Don-Doncow, Nicholas, et al.
Publicado: (2021) -
T-Cell Accumulation in the Hypertensive Brain: A Role for Sphingosine-1-Phosphate-Mediated Chemotaxis
por: Don-Doncow, Nicholas, et al.
Publicado: (2019)